Cargando…
Post-natalizumab disease reactivation in multiple sclerosis: systematic review and meta-analysis
BACKGROUND: Natalizumab (NTZ) is sometimes discontinued in patients with multiple sclerosis, mainly due to concerns about the risk of progressive multifocal leukoencephalopathy. However, NTZ interruption may result in recrudescence of disease activity. OBJECTIVE: The objective of this study was to s...
Autores principales: | Prosperini, Luca, Kinkel, Revere P., Miravalle, Augusto A., Iaffaldano, Pietro, Fantaccini, Simone |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444403/ https://www.ncbi.nlm.nih.gov/pubmed/30956686 http://dx.doi.org/10.1177/1756286419837809 |
Ejemplares similares
-
Effects of non-invasive brain stimulation in multiple sclerosis: systematic review and meta-analysis
por: Kan, Rebecca L.D., et al.
Publicado: (2022) -
Disease‐modifying therapies and T1 hypointense lesions in patients with multiple sclerosis: A systematic review and meta‐analysis
por: Valizadeh, Amir, et al.
Publicado: (2022) -
Improving pediatric multiple sclerosis interventional phase III study design: a meta-analysis
por: Graves, Jennifer S., et al.
Publicado: (2022) -
Correlation between the clinical disability and T1 hypointense lesions’ volume in cerebral magnetic resonance imaging of multiple sclerosis patients: A systematic review and meta‐analysis
por: Valizadeh, Amir, et al.
Publicado: (2021) -
Association between C-reactive protein and risk of schizophrenia: An updated meta-analysis
por: Wang, Zhichao, et al.
Publicado: (2017)